Inari Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, June 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI).
Shareholders who purchased shares of NARI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=83233&from=4
CLASS PERIOD: February 23, 2022 to February 28, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company deceived the investing public, including plaintiff; (ii) cause the market price of Inari common stock to trade above its true value; and (iii) cause plaintiff as well as other class members to purchase or otherwise acquire Inari common stock at artificially inflated prices that did not reflect the stock's true value during the class period. In furtherance of their unlawful scheme, plan, or course of conduct, defendants took the actions alleged herein.
DEADLINE: July 12, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=83233&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NARI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 12, 2024. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download multimedia:https://www.prnewswire.com/news-releases/inari-medical-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-july-12-2024-to-discuss-your-rights--nari-302167342.html
SOURCE The Gross Law Firm
Ausgewählte Hebelprodukte auf Inari Medical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Inari Medical
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Inari Medical Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Inari Medical Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Inari Medical nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.
